Sai Life Sciences IPO Peer Comparison
Sai Life Sciences Limited peer comparison with similar listed entities. (As on March 28, 2024)
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|
| Sai Life Sciences Limited | 4.57 | 4.53 | 53.83 | | 8.5 | | Consolidated |
| DIVI'S LABORATORIES Limited | 60.27 | 60.27 | 511.21 | 103.04 | 11.79 | 6.72 | Consolidated |
| Suven Pharmaceuticals Limited | 11.8 | 11.8 | 94.04 | 109.37 | 14.64 | 7.2 | Consolidated |
| Syngene International Ltd | 12.71 | 12.69 | 105.91 | 73.59 | 11.98 | 6.69 | Consolidated |
All the financial information for listed industry peers mentioned above is consolidated and sourced from the respective company's audited financial statements for the year ended March 31, 2024, as available on the Stock Exchange websites.
The peer group's P/E ratio has been computed based on the closing market price of equity shares on BSE as of July 26, 2024, divided by the diluted EPS.
Notes:
- Basic and diluted earnings/ (loss) per equity share: Basic and diluted earnings/ (loss) per equity share are computed by Indian Accounting Standard 33 notified under the Companies (Indian Accounting Standards) Rules of 2015 (as amended).
- Net Asset Value per share = Restated equity attributable to owners of our Company / total number of equity shares outstanding during the period.
- Return on Net Worth (%) = Restated net profit/(loss) after tax for the years/period attributable to the owners of our Company / by the Net worth as on the last date of the respective period.
